Computerized systems are central to every GxP process but ensuring they perform reliably and compliantly requires structure and discipline.
This session lays the groundwork: what CSV means, why it exists, and how risk-based approaches ensure trust in system performance, product quality, and patient safety.
Participants will:
- Define CSV and its role in maintaining product quality and data integrity.
- Identify key regulatory drivers (FDA 21 CFR Part 11, EU Annex 11, GAMP 5).
- Understand the CSV lifecycle (planning, specification, verification, reporting).
- Recognize how critical thinking and CSA principles modernize validation.
- Build shared understanding between IT, QA, and Business roles.
Key Takeaways
- Validation = documented evidence of control.
- Focus on what is critical - not on volume of documentation.
- Collaboration between IT, QA, and Business is essential for compliance and efficiency.
AGENDA
Introduction: Why validation still matters
Regulatory framework and expectations
CSV lifecycle and documentation hierarchy
Risk-based validation and CSA principles
Common pitfalls and good practices
Conclusion and Q&A
ADDITIONAL INFO
When:
Thursday, November 13, 2025 · 4:00 p.m.
Berlin
Abubakar is a Consultant at GxP-CC. He studied Molecular Biology at LMU Munich and brings a strong background in quality, regulatory compliance, and project management. He supports clients in solving complex compliance challenges and in developing...
Justo J. Espinosa is the Operations Officer at GxP-CC, with over 17 years of experience in the consulting industry. Before entering the private sector, Justo spent 10 years in the US Government service.
James R. Francum is a highly experienced expert in Life Science Compliance services, with over 20 years of experience in the professional services field. As the CEO of GxP-CC, James leads organizations’ compliance projects, focusing on the most...